Pages that link to "Q37863134"
Jump to navigation
Jump to search
The following pages link to Cell death and nonalcoholic steatohepatitis: where is ballooning relevant? (Q37863134):
Displaying 19 items.
- Non-alcoholic fatty liver disease: what the clinician needs to know (Q24563068) (← links)
- Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis. (Q30365017) (← links)
- Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation (Q33755829) (← links)
- The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis (Q34252404) (← links)
- Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouse. (Q34294773) (← links)
- Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation (Q34988970) (← links)
- The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes (Q35048289) (← links)
- Nonalcoholic Steatohepatitis: A Search for Factual Animal Models (Q35612535) (← links)
- NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. (Q35931190) (← links)
- The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease (Q35984078) (← links)
- Acidophil bodies in nonalcoholic steatohepatitis (Q37638658) (← links)
- Deferoxamine ameliorates hepatosteatosis via several mechanisms in ob/ob mice (Q38291587) (← links)
- Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study (Q41686499) (← links)
- Cyclooxygenase-2 promotes hepatocellular apoptosis by interacting with TNF-α and IL-6 in the pathogenesis of nonalcoholic steatohepatitis in rats (Q42249904) (← links)
- Fatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid (Q47150578) (← links)
- Nuclear Her2 expression in hepatocytes in liver disease (Q50091796) (← links)
- Apoptosis and non-alcoholic fatty liver diseases. (Q55503094) (← links)
- Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease (Q88431630) (← links)
- Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis (Q89650897) (← links)